168 related articles for article (PubMed ID: 14522526)
1. Ischaemic tolerance: a window to endogenous neuroprotection?
Schaller B; Graf R; Jacobs AH
Lancet; 2003 Sep; 362(9389):1007-8. PubMed ID: 14522526
[No Abstract] [Full Text] [Related]
2. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states.
Stenzel-Poore MP; Stevens SL; Xiong Z; Lessov NS; Harrington CA; Mori M; Meller R; Rosenzweig HL; Tobar E; Shaw TE; Chu X; Simon RP
Lancet; 2003 Sep; 362(9389):1028-37. PubMed ID: 14522533
[TBL] [Abstract][Full Text] [Related]
3. Ischemic tolerance and endogenous neuroprotection.
Dirnagl U; Simon RP; Hallenbeck JM
Trends Neurosci; 2003 May; 26(5):248-54. PubMed ID: 12744841
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with neuroprotectants and thrombolytics in acute ischaemic stroke.
Steiner T; Hacke W
Eur Neurol; 1998 Jul; 40(1):1-8. PubMed ID: 9693224
[TBL] [Abstract][Full Text] [Related]
5. Protecting neurons.
Ferriero DM
Epilepsia; 2005; 46 Suppl 7():45-51. PubMed ID: 16201995
[TBL] [Abstract][Full Text] [Related]
6. Ischemic preconditioning: a novel target for neuroprotective therapy.
Blanco M; Lizasoain I; Sobrino T; Vivancos J; Castillo J
Cerebrovasc Dis; 2006; 21 Suppl 2():38-47. PubMed ID: 16651813
[TBL] [Abstract][Full Text] [Related]
7. Autophagy activation is involved in neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats.
Yan W; Zhang H; Bai X; Lu Y; Dong H; Xiong L
Brain Res; 2011 Jul; 1402():109-21. PubMed ID: 21684529
[TBL] [Abstract][Full Text] [Related]
8. Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy.
Pignataro G; Scorziello A; Di Renzo G; Annunziato L
FEBS J; 2009 Jan; 276(1):46-57. PubMed ID: 19087199
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of the damaging action of cerebral ischemia and neuroprotection].
Skvortsova VI
Vestn Ross Akad Med Nauk; 2003; (11):74-80. PubMed ID: 14692122
[No Abstract] [Full Text] [Related]
10. Pathophysiology and treatment of cerebral ischemia.
Nagahiro S; Uno M; Sato K; Goto S; Morioka M; Ushio Y
J Med Invest; 1998 Aug; 45(1-4):57-70. PubMed ID: 9864965
[TBL] [Abstract][Full Text] [Related]
11. The effects of exercise preconditioning on cerebral blood flow change and endothelin-1 expression after cerebral ischemia in rats.
Zhang Q; Zhang L; Yang X; Wan Y; Jia J
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1696-702. PubMed ID: 24774439
[TBL] [Abstract][Full Text] [Related]
12. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
Wang CX; Ding X; Shuaib A
Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
[TBL] [Abstract][Full Text] [Related]
13. Effect of ischemic preconditioning on cerebral blood flow after subsequent lethal ischemia in gerbils.
Nakamura H; Katsumata T; Nishiyama Y; Otori T; Katsura K; Katayama Y
Life Sci; 2006 Mar; 78(15):1713-9. PubMed ID: 16253278
[TBL] [Abstract][Full Text] [Related]
14. Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats.
Yang Q; Dong H; Deng J; Wang Q; Ye R; Li X; Hu S; Dong H; Xiong L
Anesth Analg; 2011 Apr; 112(4):931-7. PubMed ID: 21385986
[TBL] [Abstract][Full Text] [Related]
15. Cerebral preconditioning and ischaemic tolerance.
Gidday JM
Nat Rev Neurosci; 2006 Jun; 7(6):437-48. PubMed ID: 16715053
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection in cerebrovascular disease.
Jain KK
Expert Opin Investig Drugs; 2000 Apr; 9(4):695-711. PubMed ID: 11060703
[TBL] [Abstract][Full Text] [Related]
17. Sarcosine preconditioning induces ischemic tolerance against global cerebral ischemia.
Pinto MC; Simão F; da Costa FL; Rosa DV; de Paiva MJ; Resende RR; Romano-Silva MA; Gomez MV; Gomez RS
Neuroscience; 2014 Jun; 271():160-9. PubMed ID: 24797328
[TBL] [Abstract][Full Text] [Related]
18. Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention?
Schaller B; Graf R
J Neurol; 2002 Nov; 249(11):1503-11. PubMed ID: 12420088
[TBL] [Abstract][Full Text] [Related]
19. Ischemic tolerance in the brain.
Kapinya KJ
Acta Physiol Hung; 2005; 92(1):67-92. PubMed ID: 16003947
[TBL] [Abstract][Full Text] [Related]
20. C-EPO: ready for prime-time preconditioning?
Kennedy J; Buchan AM
Cerebrovasc Dis; 2005; 19(4):272-3; discussion 273. PubMed ID: 15731559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
